Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (411-420 of 903) with videos related to

Pageof 91
Sort By:
International Journal of Geriatric Psychiatry|September 7, 2006
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS StudyMani S Krishnan, John T O'Brien, Michael J Firbank, et al.
Dementia and Geriatric Cognitive Disorders|February 10, 2007
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controlsYolande A L Pijnenburg, John C Janssen, Niki S M Schoonenboom, et al.
Dementia and Geriatric Cognitive Disorders|August 6, 2008
Early-onset dementia is associated with higher mortalityEsther L G E Koedam, Yolande A L Pijnenburg, Dorly J H Deeg, et al.
Alzheimer'S Research & Therapy|August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIADE G B Vijverberg, T M Axelsen, A R Bihlet, et al.
The Journal of Prevention of Alzheimer'S Disease|October 18, 2025
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular diseaseMichael H Davidson, Michael Szarek, Philip Scheltens, et al.
Alzheimer'S Research & Therapy|January 18, 2017
Diagnostic impact of [<sup>18</sup>F]flutemetamol PET in early-onset dementiaMarissa D Zwan, Femke H Bouwman, Elles Konijnenberg, et al.
Alzheimer'S Research & Therapy|February 21, 2018
Disease-related determinants are associated with mortality in dementia due to Alzheimer's diseaseHanneke F M Rhodius-Meester, Hilkka Liedes, Ted Koene, et al.
Stroke|June 10, 2017
Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)Jan Willem van Dalen, Eric P Moll van Charante, Matthan W A Caan, et al.
Alzheimer'S Research & Therapy|December 28, 2020
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive declineJulia Stockmann, Inge M W Verberk, Nina Timmesfeld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2012
Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementiaEsther L G E Koedam, Annelies E van der Vlies, Wiesje M van der Flier, et al.
Pageof 91

Showing results (411-420 of 903) with videos related to

Sort By:
Pageof 91
International Journal of Geriatric Psychiatry|September 7, 2006
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS StudyMani S Krishnan, John T O'Brien, Michael J Firbank, et al.
Dementia and Geriatric Cognitive Disorders|February 10, 2007
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controlsYolande A L Pijnenburg, John C Janssen, Niki S M Schoonenboom, et al.
Dementia and Geriatric Cognitive Disorders|August 6, 2008
Early-onset dementia is associated with higher mortalityEsther L G E Koedam, Yolande A L Pijnenburg, Dorly J H Deeg, et al.
Alzheimer'S Research & Therapy|August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIADE G B Vijverberg, T M Axelsen, A R Bihlet, et al.
The Journal of Prevention of Alzheimer'S Disease|October 18, 2025
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular diseaseMichael H Davidson, Michael Szarek, Philip Scheltens, et al.
Alzheimer'S Research & Therapy|January 18, 2017
Diagnostic impact of [<sup>18</sup>F]flutemetamol PET in early-onset dementiaMarissa D Zwan, Femke H Bouwman, Elles Konijnenberg, et al.
Alzheimer'S Research & Therapy|February 21, 2018
Disease-related determinants are associated with mortality in dementia due to Alzheimer's diseaseHanneke F M Rhodius-Meester, Hilkka Liedes, Ted Koene, et al.
Stroke|June 10, 2017
Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)Jan Willem van Dalen, Eric P Moll van Charante, Matthan W A Caan, et al.
Alzheimer'S Research & Therapy|December 28, 2020
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive declineJulia Stockmann, Inge M W Verberk, Nina Timmesfeld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2012
Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementiaEsther L G E Koedam, Annelies E van der Vlies, Wiesje M van der Flier, et al.
Pageof 91